BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7546632)

  • 1. Interactions between endothelial secretogogues.
    Gryglewski RJ
    Ann Med; 1995 Jun; 27(3):421-7. PubMed ID: 7546632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide, prostacyclin (PGI2) and tissue plasminogen activator (t-PA): alliance or neutrality?
    Gryglewski RJ
    Pol J Pharmacol; 1995; 47(5):467-72. PubMed ID: 8868142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between endothelial mediators.
    Gryglewski RJ
    Pharmacol Toxicol; 1995 Jul; 77(1):1-9. PubMed ID: 8532605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bradykinin as a major endogenous regulator of endothelial function.
    Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
    Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall.
    Kawai C
    Circulation; 1994 Aug; 90(2):1033-43. PubMed ID: 8044917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelial factors and thrombocyte function].
    Schrör K
    Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin, nitric oxide, and atherosclerosis.
    Gryglewski RJ; Chłopicki S; Swies J; Niezabitowski P
    Ann N Y Acad Sci; 1995 Jan; 748():194-206; discussion 206-7. PubMed ID: 7695165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels.
    Chaudhuri G; Cuevas J; Buga GM; Ignarro LJ
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2036-43. PubMed ID: 8285242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of nitric oxide and prostacyclin synthesis in endothelial cells.
    Busse R; Hecker M; Fleming I
    Arzneimittelforschung; 1994 Mar; 44(3A):392-6. PubMed ID: 8185712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial release of tissue-type plasminogen activator in the human forearm: role of nitric oxide.
    Smith DT; Hoetzer GL; Greiner JJ; Stauffer BL; DeSouza CA
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):311-4. PubMed ID: 12883337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
    Warner TD
    Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet.
    Hardy P; Abran D; Hou X; Lahaie I; Peri KG; Asselin P; Varma DR; Chemtob S
    Circ Res; 1998 Oct; 83(7):721-9. PubMed ID: 9758642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
    Curwen KD; Gimbrone MA; Handin RI
    Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
    Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein.
    Barker JE; Bakhle YS; Anderson J; Treasure T; Piper PJ
    Br J Pharmacol; 1996 Jun; 118(3):643-8. PubMed ID: 8762089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells.
    Bird IM; Sullivan JA; Di T; Cale JM; Zhang L; Zheng J; Magness RR
    Endocrinology; 2000 Mar; 141(3):1107-17. PubMed ID: 10698187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.